# Elastic timeline entity: /record/elastic.md id: ent_elastic ## undated - undated to 2017-06-05 | registrant_name | Elastic N.V. | superseded | [clm_0493781751E6](/claim/clm_0493781751E6.md) - undated | ticker | ESTC | valid | [clm_0FACB9D68560](/claim/clm_0FACB9D68560.md) - undated | cik | 0001707753 | valid | [clm_2872F8AC22EA](/claim/clm_2872F8AC22EA.md) - undated | fiscal_year_end | 04-30 | valid | [clm_56CC6255455B](/claim/clm_56CC6255455B.md) - undated | listed_on | NYSE | valid | [clm_8961925FC3BB](/claim/clm_8961925FC3BB.md) - undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_E506A9B26907](/claim/clm_E506A9B26907.md) ## 2009 - 2009-10-23 | x_username | elastic | unverified | [clm_9240917C72ED](/claim/clm_9240917C72ED.md) ## undated - undated | website | https://www.elastic.co | unverified | [clm_343CA083119E](/claim/clm_343CA083119E.md) - undated | member_of | [Linux Foundation](/record/linux-foundation.md) | unverified | [clm_3EE5297D17ED](/claim/clm_3EE5297D17ED.md) - undated | member_of | CVE Numbering Authority | unverified | [clm_56B126F9D274](/claim/clm_56B126F9D274.md) - undated | headquarters | Mountain View | unverified | [clm_5C9FD29DBF76](/claim/clm_5C9FD29DBF76.md) - undated | website | http://www.elastic.co/ | unverified | [clm_77DB1FF73817](/claim/clm_77DB1FF73817.md) - undated | member_of | Business Software Alliance | unverified | [clm_AB7079E2CE73](/claim/clm_AB7079E2CE73.md) - undated | country | United States | unverified | [clm_D2E793983BBF](/claim/clm_D2E793983BBF.md) ## 2012 - 2012-02-01 | founded | 2012-02-01 | unverified | [clm_DBB67AA6CA23](/claim/clm_DBB67AA6CA23.md) ## 2016 - 2016-04-30 to 2017-04-30 | total_equity | -102,902,000 United States dollar | superseded | [clm_22916DBE0306](/claim/clm_22916DBE0306.md) ## 2017 - 2017-04-30 to 2017-10-31 | total_equity | -128,538,000 United States dollar | superseded | [clm_0EACB0BBA468](/claim/clm_0EACB0BBA468.md) - 2017-04-30 to 2018-04-30 | research_and_development | 32,601,000 United States dollar | superseded | [clm_12CF6D1FFC9F](/claim/clm_12CF6D1FFC9F.md) - 2017-04-30 to 2018-04-30 | net_income | -51,968,000 United States dollar | superseded | [clm_B007C1168ABA](/claim/clm_B007C1168ABA.md) - 2017-04-30 to 2018-04-30 | revenue | 88,177,000 United States dollar | superseded | [clm_B5E58A0AFBF4](/claim/clm_B5E58A0AFBF4.md) - 2017-04-30 to 2018-04-30 | operating_income | -47,172,000 United States dollar | superseded | [clm_D8798395EC41](/claim/clm_D8798395EC41.md) - 2017-06-05 to 2017-11-13 | registrant_name | Elasticsearch Global BV | superseded | [clm_70B387E1C442](/claim/clm_70B387E1C442.md) - 2017-10-31 to 2018-01-31 | quarterly_revenue | 37,038,000 United States dollar | superseded | [clm_5D2E4A32F231](/claim/clm_5D2E4A32F231.md) - 2017-10-31 to 2018-01-31 | quarterly_operating_income | -7,126,000 United States dollar | superseded | [clm_7355F6BE56E5](/claim/clm_7355F6BE56E5.md) - 2017-10-31 to 2018-01-31 | quarterly_research_and_development | 12,182,000 United States dollar | superseded | [clm_DFFCCD768B0B](/claim/clm_DFFCCD768B0B.md) - 2017-10-31 to 2018-01-31 | total_equity | -128,748,000 United States dollar | superseded | [clm_F616176F286D](/claim/clm_F616176F286D.md) - 2017-10-31 to 2018-01-31 | quarterly_net_income | -8,027,000 United States dollar | superseded | [clm_FB21CF679E6C](/claim/clm_FB21CF679E6C.md) ## 2018 - 2018-01-31 to 2018-04-30 | total_equity | -136,886,000 United States dollar | superseded | [clm_035E8D499067](/claim/clm_035E8D499067.md) - 2018-01-31 to 2018-07-31 | quarterly_operating_income | -12,459,000 United States dollar | superseded | [clm_450B2A7D7808](/claim/clm_450B2A7D7808.md) - 2018-01-31 to 2018-07-31 | quarterly_research_and_development | 15,092,000 United States dollar | superseded | [clm_7D71AD4104F9](/claim/clm_7D71AD4104F9.md) - 2018-01-31 to 2018-07-31 | quarterly_revenue | 41,681,000 United States dollar | superseded | [clm_8279B2A760DB](/claim/clm_8279B2A760DB.md) - 2018-01-31 to 2018-07-31 | quarterly_net_income | -13,330,000 United States dollar | superseded | [clm_97C2DC3ADB33](/claim/clm_97C2DC3ADB33.md) - 2018-04-30 to 2018-10-31 | cash_and_equivalents | 50,941,000 United States dollar | superseded | [clm_1A75CB6C7347](/claim/clm_1A75CB6C7347.md) - 2018-04-30 to 2019-04-30 | revenue | 159,935,000 United States dollar | superseded | [clm_333E62021627](/claim/clm_333E62021627.md) - 2018-04-30 to 2018-10-31 | total_assets | 183,013,000 United States dollar | superseded | [clm_703AE6D10070](/claim/clm_703AE6D10070.md) - 2018-04-30 to 2019-04-30 | net_income | -52,727,000 United States dollar | superseded | [clm_76584C83F586](/claim/clm_76584C83F586.md) - 2018-04-30 to 2018-07-31 | total_equity | -153,529,000 United States dollar | superseded | [clm_86D46A8EB9B7](/claim/clm_86D46A8EB9B7.md) - 2018-04-30 to 2019-04-30 | research_and_development | 55,641,000 United States dollar | superseded | [clm_AD2E261C1631](/claim/clm_AD2E261C1631.md) - 2018-04-30 to 2019-04-30 | operating_income | -47,994,000 United States dollar | superseded | [clm_C4D50EFBE248](/claim/clm_C4D50EFBE248.md) - 2018-07-31 to 2018-10-31 | total_equity | -166,319,000 United States dollar | superseded | [clm_230FDBB9D03C](/claim/clm_230FDBB9D03C.md) - 2018-07-31 to 2018-10-31 | quarterly_research_and_development | 18,981,000 United States dollar | superseded | [clm_450B18BB1301](/claim/clm_450B18BB1301.md) - 2018-07-31 to 2018-10-31 | quarterly_net_income | -18,578,000 United States dollar | superseded | [clm_81A1A202D814](/claim/clm_81A1A202D814.md) - 2018-07-31 to 2018-10-31 | quarterly_revenue | 56,644,000 United States dollar | superseded | [clm_ED780501F2D6](/claim/clm_ED780501F2D6.md) - 2018-07-31 to 2018-10-31 | quarterly_operating_income | -18,415,000 United States dollar | superseded | [clm_FC894DA99283](/claim/clm_FC894DA99283.md) - 2018-10-05 | listed_on | New York Stock Exchange | valid | [clm_F5AC37735CED](/claim/clm_F5AC37735CED.md) - 2018-10-31 to 2019-01-31 | quarterly_operating_income | -27,070,000 United States dollar | superseded | [clm_423018FDCF1F](/claim/clm_423018FDCF1F.md) - 2018-10-31 to 2019-01-31 | quarterly_research_and_development | 25,332,000 United States dollar | superseded | [clm_485349DCA9DC](/claim/clm_485349DCA9DC.md) - 2018-10-31 to 2019-01-31 | quarterly_net_income | -27,539,000 United States dollar | superseded | [clm_6C33A76A3CBF](/claim/clm_6C33A76A3CBF.md) - 2018-10-31 to 2019-01-31 | quarterly_revenue | 63,575,000 United States dollar | superseded | [clm_6D1EAB271E8E](/claim/clm_6D1EAB271E8E.md) - 2018-10-31 to 2019-01-31 | total_assets | 459,531,000 United States dollar | superseded | [clm_989131D98C35](/claim/clm_989131D98C35.md) - 2018-10-31 to 2019-01-31 | total_equity | 283,886,000 United States dollar | superseded | [clm_A57BB18CD449](/claim/clm_A57BB18CD449.md) - 2018-10-31 to 2019-01-31 | cash_and_equivalents | 318,564,000 United States dollar | superseded | [clm_D397464DBC1E](/claim/clm_D397464DBC1E.md) - 2018-11-30 to 2019-02-26 | shares_outstanding | 70,973,965 shares | superseded | [clm_0EA47715EB26](/claim/clm_0EA47715EB26.md) ## 2019 - 2019-01-31 to 2019-04-30 | total_equity | 272,099,000 United States dollar | superseded | [clm_037907C8A2A5](/claim/clm_037907C8A2A5.md) - 2019-01-31 to 2019-07-31 | quarterly_research_and_development | 25,850,000 United States dollar | superseded | [clm_1606B174C30A](/claim/clm_1606B174C30A.md) - 2019-01-31 to 2019-07-31 | quarterly_operating_income | -23,786,000 United States dollar | superseded | [clm_45CDE3A26C2C](/claim/clm_45CDE3A26C2C.md) - 2019-01-31 to 2019-04-30 | cash_and_equivalents | 305,826,000 United States dollar | superseded | [clm_55E8BF2FB25C](/claim/clm_55E8BF2FB25C.md) - 2019-01-31 to 2019-07-31 | quarterly_revenue | 70,835,000 United States dollar | superseded | [clm_6E43E239A634](/claim/clm_6E43E239A634.md) - 2019-01-31 to 2019-04-30 | total_assets | 450,998,000 United States dollar | superseded | [clm_926AED421B4A](/claim/clm_926AED421B4A.md) - 2019-01-31 to 2019-07-31 | quarterly_net_income | -21,351,000 United States dollar | superseded | [clm_EEED6FDD2844](/claim/clm_EEED6FDD2844.md) - 2019-02-26 to 2019-06-20 | shares_outstanding | 71,364,083 shares | superseded | [clm_D8D26EB13F9A](/claim/clm_D8D26EB13F9A.md) - 2019-04-30 to 2020-04-30 | research_and_development | 101,167,000 United States dollar | superseded | [clm_1795BECC2792](/claim/clm_1795BECC2792.md) - 2019-04-30 to 2020-04-30 | operating_income | -101,356,000 United States dollar | superseded | [clm_3E0E812E4B41](/claim/clm_3E0E812E4B41.md) - 2019-04-30 to 2019-07-31 | total_equity | 263,012,000 United States dollar | superseded | [clm_7F36D1D12102](/claim/clm_7F36D1D12102.md) - 2019-04-30 to 2020-04-30 | revenue | 271,653,000 United States dollar | superseded | [clm_8882039F0DB2](/claim/clm_8882039F0DB2.md) - 2019-04-30 to 2020-04-30 | net_income | -102,303,000 United States dollar | superseded | [clm_C699F0EC374F](/claim/clm_C699F0EC374F.md) - 2019-04-30 to 2019-07-31 | total_assets | 485,738,000 United States dollar | superseded | [clm_C8352B5047F7](/claim/clm_C8352B5047F7.md) - 2019-04-30 to 2019-07-31 | cash_and_equivalents | 298,000,000 United States dollar | superseded | [clm_F5CB93848D25](/claim/clm_F5CB93848D25.md) - 2019-06-20 to 2019-08-31 | shares_outstanding | 75,354,059 shares | superseded | [clm_1820D5BA378C](/claim/clm_1820D5BA378C.md) - 2019-07-31 to 2019-10-31 | quarterly_operating_income | -42,302,000 United States dollar | superseded | [clm_2741979DE492](/claim/clm_2741979DE492.md) - 2019-07-31 to 2019-10-31 | cash_and_equivalents | 315,152,000 United States dollar | superseded | [clm_2AC445D6DF76](/claim/clm_2AC445D6DF76.md) - 2019-07-31 to 2019-10-31 | total_equity | 255,050,000 United States dollar | superseded | [clm_3C5AB9EACD75](/claim/clm_3C5AB9EACD75.md) - 2019-07-31 to 2019-10-31 | total_assets | 505,736,000 United States dollar | superseded | [clm_461D0505D26F](/claim/clm_461D0505D26F.md) - 2019-07-31 to 2019-10-31 | quarterly_revenue | 89,710,000 United States dollar | superseded | [clm_6EBF43259014](/claim/clm_6EBF43259014.md) - 2019-07-31 to 2019-10-31 | quarterly_net_income | -41,769,000 United States dollar | superseded | [clm_C0E85DD06B35](/claim/clm_C0E85DD06B35.md) - 2019-07-31 to 2019-10-31 | quarterly_research_and_development | 35,182,000 United States dollar | superseded | [clm_CA9962E63681](/claim/clm_CA9962E63681.md) - 2019-08-31 to 2019-11-30 | shares_outstanding | 76,555,686 shares | superseded | [clm_5F4D70EE2020](/claim/clm_5F4D70EE2020.md) - 2019-10-31 to 2020-01-31 | cash_and_equivalents | 305,246,000 United States dollar | superseded | [clm_373EBE35AE5A](/claim/clm_373EBE35AE5A.md) - 2019-10-31 to 2020-01-31 | total_equity | 433,156,000 United States dollar | superseded | [clm_408F192F4C32](/claim/clm_408F192F4C32.md) - 2019-10-31 to 2020-01-31 | quarterly_operating_income | -51,961,000 United States dollar | superseded | [clm_5514C5CDDB4B](/claim/clm_5514C5CDDB4B.md) - 2019-10-31 to 2020-01-31 | quarterly_net_income | -49,973,000 United States dollar | superseded | [clm_826A25BEB654](/claim/clm_826A25BEB654.md) - 2019-10-31 to 2020-01-31 | quarterly_revenue | 101,106,000 United States dollar | superseded | [clm_95B664AB566A](/claim/clm_95B664AB566A.md) - 2019-10-31 to 2020-01-31 | quarterly_research_and_development | 38,478,000 United States dollar | superseded | [clm_E595EE114513](/claim/clm_E595EE114513.md) - 2019-10-31 to 2020-01-31 | total_assets | 766,789,000 United States dollar | superseded | [clm_FE9C54D78B2B](/claim/clm_FE9C54D78B2B.md) - 2019-11-30 to 2020-02-29 | shares_outstanding | 80,621,016 shares | superseded | [clm_4313F744BB05](/claim/clm_4313F744BB05.md) ## 2020 - 2020-01-31 to 2020-04-30 | total_equity | 418,442,000 United States dollar | superseded | [clm_129D11130CED](/claim/clm_129D11130CED.md) - 2020-01-31 to 2020-07-31 | quarterly_net_income | -44,281,000 United States dollar | superseded | [clm_8456A1AFAFEF](/claim/clm_8456A1AFAFEF.md) - 2020-01-31 to 2020-07-31 | quarterly_operating_income | -42,268,000 United States dollar | superseded | [clm_8A6D50AA3929](/claim/clm_8A6D50AA3929.md) - 2020-01-31 to 2020-04-30 | cash_and_equivalents | 294,076,000 United States dollar | superseded | [clm_9268C69DA350](/claim/clm_9268C69DA350.md) - 2020-01-31 to 2020-07-31 | quarterly_research_and_development | 46,119,000 United States dollar | superseded | [clm_991EF6891282](/claim/clm_991EF6891282.md) - 2020-01-31 to 2020-07-31 | quarterly_revenue | 113,181,000 United States dollar | superseded | [clm_A0C004EBB45D](/claim/clm_A0C004EBB45D.md) - 2020-01-31 to 2020-04-30 | total_assets | 741,849,000 United States dollar | superseded | [clm_EFC38C3DFF7A](/claim/clm_EFC38C3DFF7A.md) - 2020-02-29 to 2020-06-22 | shares_outstanding | 81,720,602 shares | superseded | [clm_8ABC5CB13A05](/claim/clm_8ABC5CB13A05.md) - 2020-04-30 to 2020-07-31 | cash_and_equivalents | 297,081,000 United States dollar | superseded | [clm_0B8BE2E968F2](/claim/clm_0B8BE2E968F2.md) - 2020-04-30 to 2021-04-30 | net_income | -167,174,000 United States dollar | superseded | [clm_0F0AC2567956](/claim/clm_0F0AC2567956.md) - 2020-04-30 to 2020-07-31 | total_assets | 803,911,000 United States dollar | superseded | [clm_19DE8A14FC7A](/claim/clm_19DE8A14FC7A.md) - 2020-04-30 to 2021-04-30 | revenue | 427,620,000 United States dollar | superseded | [clm_27D7BB489FD3](/claim/clm_27D7BB489FD3.md) - 2020-04-30 to 2021-04-30 | research_and_development | 165,370,000 United States dollar | superseded | [clm_738BA6FBB122](/claim/clm_738BA6FBB122.md) - 2020-04-30 to 2021-04-30 | operating_income | -171,105,000 United States dollar | superseded | [clm_C23ADDE494C2](/claim/clm_C23ADDE494C2.md) - 2020-04-30 to 2020-07-31 | total_equity | 413,647,000 United States dollar | superseded | [clm_F5178AEC9A0E](/claim/clm_F5178AEC9A0E.md) - 2020-06-22 to 2020-08-31 | shares_outstanding | 85,282,748 shares | superseded | [clm_1AB1FCBB63FE](/claim/clm_1AB1FCBB63FE.md) - 2020-07-31 to 2020-10-31 | quarterly_net_income | -19,001,000 United States dollar | superseded | [clm_27F5394E0CAC](/claim/clm_27F5394E0CAC.md) - 2020-07-31 to 2020-10-31 | cash_and_equivalents | 350,418,000 United States dollar | superseded | [clm_77A003C7F406](/claim/clm_77A003C7F406.md) - 2020-07-31 to 2020-10-31 | quarterly_revenue | 128,870,000 United States dollar | superseded | [clm_793EF32A8147](/claim/clm_793EF32A8147.md) - 2020-07-31 to 2020-10-31 | total_equity | 432,379,000 United States dollar | superseded | [clm_7ED30A9D9A89](/claim/clm_7ED30A9D9A89.md) - 2020-07-31 to 2020-10-31 | quarterly_research_and_development | 45,678,000 United States dollar | superseded | [clm_CB2438334E3F](/claim/clm_CB2438334E3F.md) - 2020-07-31 to 2020-10-31 | total_assets | 821,342,000 United States dollar | superseded | [clm_D3831D7F6EE9](/claim/clm_D3831D7F6EE9.md) - 2020-07-31 to 2020-10-31 | quarterly_operating_income | -29,519,000 United States dollar | superseded | [clm_EC3673BB8773](/claim/clm_EC3673BB8773.md) - 2020-08-31 to 2020-11-30 | shares_outstanding | 86,272,053 shares | superseded | [clm_884515F3751C](/claim/clm_884515F3751C.md) - 2020-10-31 to 2021-01-31 | quarterly_revenue | 144,894,000 United States dollar | superseded | [clm_4454DE972BC5](/claim/clm_4454DE972BC5.md) - 2020-10-31 to 2021-01-31 | cash_and_equivalents | 348,986,000 United States dollar | superseded | [clm_5FC720749023](/claim/clm_5FC720749023.md) - 2020-10-31 to 2021-01-31 | total_equity | 442,657,000 United States dollar | superseded | [clm_AE411D786D2E](/claim/clm_AE411D786D2E.md) - 2020-10-31 to 2021-01-31 | quarterly_operating_income | -28,421,000 United States dollar | superseded | [clm_EC137C526036](/claim/clm_EC137C526036.md) - 2020-10-31 to 2021-01-31 | quarterly_net_income | -29,158,000 United States dollar | superseded | [clm_F65AAFA77886](/claim/clm_F65AAFA77886.md) - 2020-10-31 to 2021-01-31 | quarterly_research_and_development | 46,688,000 United States dollar | superseded | [clm_F7785D3566DE](/claim/clm_F7785D3566DE.md) - 2020-10-31 to 2021-01-31 | total_assets | 867,561,000 United States dollar | superseded | [clm_FE1413E9D9B8](/claim/clm_FE1413E9D9B8.md) - 2020-11-30 to 2021-02-24 | shares_outstanding | 87,403,657 shares | superseded | [clm_CBAF323186CD](/claim/clm_CBAF323186CD.md) ## 2021 - 2021-01-31 to 2021-04-30 | total_equity | 455,581,000 United States dollar | superseded | [clm_14462ED430CA](/claim/clm_14462ED430CA.md) - 2021-01-31 to 2021-04-30 | total_assets | 899,980,000 United States dollar | superseded | [clm_2F611CA68A87](/claim/clm_2F611CA68A87.md) - 2021-01-31 to 2021-07-31 | quarterly_net_income | -37,974,000 United States dollar | superseded | [clm_3A027CFC1729](/claim/clm_3A027CFC1729.md) - 2021-01-31 to 2021-04-30 | cash_and_equivalents | 393,134,000 United States dollar | superseded | [clm_42672DDADADB](/claim/clm_42672DDADADB.md) - 2021-01-31 to 2021-07-31 | quarterly_revenue | 157,115,000 United States dollar | superseded | [clm_4DC1CFA55022](/claim/clm_4DC1CFA55022.md) - 2021-01-31 to 2021-07-31 | quarterly_research_and_development | 51,400,000 United States dollar | superseded | [clm_7F9ECFA863E3](/claim/clm_7F9ECFA863E3.md) - 2021-01-31 to 2021-07-31 | quarterly_operating_income | -34,461,000 United States dollar | superseded | [clm_DF16DFC0D374](/claim/clm_DF16DFC0D374.md) - 2021-02-24 to 2021-06-21 | shares_outstanding | 89,764,796 shares | superseded | [clm_7173C6687831](/claim/clm_7173C6687831.md) - 2021-04-30 to 2022-04-30 | research_and_development | 199,203,000 United States dollar | superseded | [clm_0C40C3DE0841](/claim/clm_0C40C3DE0841.md) - 2021-04-30 to 2022-04-30 | operating_income | -129,478,000 United States dollar | superseded | [clm_12E915A2D45E](/claim/clm_12E915A2D45E.md) - 2021-04-30 to 2021-07-31 | total_equity | 450,831,000 United States dollar | superseded | [clm_159F171378A0](/claim/clm_159F171378A0.md) - 2021-04-30 to 2021-07-31 | cash_and_equivalents | 400,814,000 United States dollar | superseded | [clm_45C39685493B](/claim/clm_45C39685493B.md) - 2021-04-30 to 2022-04-30 | revenue | 608,489,000 United States dollar | superseded | [clm_84B89FDE247C](/claim/clm_84B89FDE247C.md) - 2021-04-30 to 2022-04-30 | net_income | -129,434,000 United States dollar | superseded | [clm_C7F06224C4C8](/claim/clm_C7F06224C4C8.md) - 2021-04-30 to 2021-07-31 | total_assets | 973,172,000 United States dollar | superseded | [clm_D9C66F681831](/claim/clm_D9C66F681831.md) - 2021-06-01 | member_of | OpenStreetMap Foundation | unverified | [clm_AE51B335517B](/claim/clm_AE51B335517B.md) - 2021-06-21 to 2021-08-23 | shares_outstanding | 91,502,880 shares | superseded | [clm_65911ED371F5](/claim/clm_65911ED371F5.md) - 2021-07-31 to 2021-10-31 | quarterly_operating_income | -31,034,000 United States dollar | superseded | [clm_2A07A64538B6](/claim/clm_2A07A64538B6.md) - 2021-07-31 to 2021-10-31 | total_assets | 1,519,885,000 United States dollar | superseded | [clm_5699E5A32AAC](/claim/clm_5699E5A32AAC.md) - 2021-07-31 to 2021-10-31 | total_equity | 455,663,000 United States dollar | superseded | [clm_83A892480D4F](/claim/clm_83A892480D4F.md) - 2021-07-31 to 2021-10-31 | cash_and_equivalents | 991,342,000 United States dollar | superseded | [clm_8863898AD7AB](/claim/clm_8863898AD7AB.md) - 2021-07-31 to 2021-10-31 | quarterly_net_income | -34,489,000 United States dollar | superseded | [clm_98CDBF3AE048](/claim/clm_98CDBF3AE048.md) - 2021-07-31 to 2021-10-31 | quarterly_research_and_development | 59,382,000 United States dollar | superseded | [clm_CE8090F420C4](/claim/clm_CE8090F420C4.md) - 2021-07-31 to 2021-10-31 | quarterly_revenue | 193,095,000 United States dollar | superseded | [clm_F9CF075A90A3](/claim/clm_F9CF075A90A3.md) - 2021-08-23 to 2021-11-30 | shares_outstanding | 91,795,800 shares | superseded | [clm_3DEFF8B80296](/claim/clm_3DEFF8B80296.md) - 2021-10-31 to 2022-01-31 | cash_and_equivalents | 876,059,000 United States dollar | superseded | [clm_24CE2CF30ED5](/claim/clm_24CE2CF30ED5.md) - 2021-10-31 to 2022-01-31 | total_equity | 449,800,000 United States dollar | superseded | [clm_38054C5DED4E](/claim/clm_38054C5DED4E.md) - 2021-10-31 to 2022-01-31 | quarterly_net_income | -47,023,000 United States dollar | superseded | [clm_3A5961989AF9](/claim/clm_3A5961989AF9.md) - 2021-10-31 to 2022-01-31 | quarterly_research_and_development | 63,763,000 United States dollar | superseded | [clm_5DE918A6B2D2](/claim/clm_5DE918A6B2D2.md) - 2021-10-31 to 2022-01-31 | quarterly_operating_income | -37,175,000 United States dollar | superseded | [clm_77BB1AB8E350](/claim/clm_77BB1AB8E350.md) - 2021-10-31 to 2022-01-31 | quarterly_revenue | 205,980,000 United States dollar | superseded | [clm_795939D99101](/claim/clm_795939D99101.md) - 2021-10-31 to 2022-01-31 | total_assets | 1,561,701,000 United States dollar | superseded | [clm_E5DCE2D09F4D](/claim/clm_E5DCE2D09F4D.md) - 2021-11-30 to 2022-02-28 | shares_outstanding | 92,613,879 shares | superseded | [clm_092583F4D353](/claim/clm_092583F4D353.md) ## 2022 - 2022-01-12 | ceo | Ashutosh Kulkarni | unverified | [clm_9759EAE761F0](/claim/clm_9759EAE761F0.md) - 2022-01-31 to 2022-07-31 | quarterly_operating_income | -45,849,000 United States dollar | superseded | [clm_30E8FB22ADED](/claim/clm_30E8FB22ADED.md) - 2022-01-31 to 2022-04-30 | total_assets | 1,559,296,000 United States dollar | superseded | [clm_3F33C4E0424E](/claim/clm_3F33C4E0424E.md) - 2022-01-31 to 2022-04-30 | cash_and_equivalents | 864,363,000 United States dollar | superseded | [clm_4148ADB34259](/claim/clm_4148ADB34259.md) - 2022-01-31 to 2022-07-31 | quarterly_revenue | 223,944,000 United States dollar | superseded | [clm_9FC2A7D148C1](/claim/clm_9FC2A7D148C1.md) - 2022-01-31 to 2022-07-31 | quarterly_research_and_development | 71,749,000 United States dollar | superseded | [clm_B9734318305A](/claim/clm_B9734318305A.md) - 2022-01-31 to 2022-04-30 | total_equity | 432,309,000 United States dollar | superseded | [clm_BF9EF46A4186](/claim/clm_BF9EF46A4186.md) - 2022-01-31 to 2022-07-31 | quarterly_net_income | -56,726,000 United States dollar | superseded | [clm_FD2FC6F763E7](/claim/clm_FD2FC6F763E7.md) - 2022-02-28 to 2022-06-16 | shares_outstanding | 93,468,991 shares | superseded | [clm_9FF287D1283A](/claim/clm_9FF287D1283A.md) - 2022-04-30 to 2022-07-31 | total_assets | 1,642,931,000 United States dollar | superseded | [clm_07ABA22AA11D](/claim/clm_07ABA22AA11D.md) - 2022-04-30 to 2023-04-30 | research_and_development | 273,761,000 United States dollar | superseded | [clm_2F6AB90605EC](/claim/clm_2F6AB90605EC.md) - 2022-04-30 to 2023-04-30 | net_income | -203,848,000 United States dollar | superseded | [clm_7F23ABCD0352](/claim/clm_7F23ABCD0352.md) - 2022-04-30 to 2022-07-31 | total_equity | 415,433,000 United States dollar | superseded | [clm_9B4ADDA8DA08](/claim/clm_9B4ADDA8DA08.md) - 2022-04-30 to 2023-04-30 | revenue | 862,374,000 United States dollar | superseded | [clm_A07017F03EDE](/claim/clm_A07017F03EDE.md) - 2022-04-30 to 2023-04-30 | operating_income | -173,680,000 United States dollar | superseded | [clm_C72017137F1D](/claim/clm_C72017137F1D.md) - 2022-04-30 to 2022-07-31 | cash_and_equivalents | 860,949,000 United States dollar | superseded | [clm_FFF525AB37A0](/claim/clm_FFF525AB37A0.md) - 2022-06-16 to 2022-08-19 | shares_outstanding | 94,857,635 shares | superseded | [clm_145065226161](/claim/clm_145065226161.md) - 2022-07-31 to 2022-10-31 | total_assets | 1,571,019,000 United States dollar | superseded | [clm_049CD5A5C852](/claim/clm_049CD5A5C852.md) - 2022-07-31 to 2022-10-31 | cash_and_equivalents | 848,761,000 United States dollar | superseded | [clm_0CF99C28F6BC](/claim/clm_0CF99C28F6BC.md) - 2022-07-31 to 2022-10-31 | quarterly_revenue | 250,081,000 United States dollar | superseded | [clm_42A2639349C3](/claim/clm_42A2639349C3.md) - 2022-07-31 to 2022-10-31 | quarterly_net_income | -69,551,000 United States dollar | superseded | [clm_4F8570EBE4C2](/claim/clm_4F8570EBE4C2.md) - 2022-07-31 to 2022-10-31 | total_equity | 393,538,000 United States dollar | superseded | [clm_501337AAAA3A](/claim/clm_501337AAAA3A.md) - 2022-07-31 to 2022-10-31 | quarterly_research_and_development | 78,649,000 United States dollar | superseded | [clm_61B628F22BB5](/claim/clm_61B628F22BB5.md) - 2022-07-31 to 2022-10-31 | quarterly_operating_income | -60,641,000 United States dollar | superseded | [clm_A982D7723CEB](/claim/clm_A982D7723CEB.md) - 2022-08-19 to 2022-11-30 | shares_outstanding | 94,986,619 shares | superseded | [clm_0540C8575F75](/claim/clm_0540C8575F75.md) - 2022-10-31 to 2023-01-31 | total_assets | 1,594,232,000 United States dollar | superseded | [clm_01E41D32C734](/claim/clm_01E41D32C734.md) - 2022-10-31 to 2023-01-31 | quarterly_revenue | 264,401,000 United States dollar | superseded | [clm_1D60962A28EA](/claim/clm_1D60962A28EA.md) - 2022-10-31 to 2023-01-31 | quarterly_research_and_development | 75,568,000 United States dollar | superseded | [clm_349B87C1E999](/claim/clm_349B87C1E999.md) - 2022-10-31 to 2023-01-31 | quarterly_net_income | -47,305,000 United States dollar | superseded | [clm_506706A3350B](/claim/clm_506706A3350B.md) - 2022-10-31 to 2023-01-31 | quarterly_operating_income | -49,028,000 United States dollar | superseded | [clm_67A464A6936D](/claim/clm_67A464A6936D.md) - 2022-10-31 to 2023-01-31 | total_equity | 391,565,000 United States dollar | superseded | [clm_CA697623F1C5](/claim/clm_CA697623F1C5.md) - 2022-10-31 to 2023-01-31 | cash_and_equivalents | 856,237,000 United States dollar | superseded | [clm_E6F692D40FB2](/claim/clm_E6F692D40FB2.md) - 2022-11-30 to 2023-02-28 | shares_outstanding | 95,605,341 shares | superseded | [clm_7F438E6DAD45](/claim/clm_7F438E6DAD45.md) ## 2023 - 2023-01-31 to 2023-04-30 | cash_and_equivalents | 877,683,000 United States dollar | superseded | [clm_0E5C9D130473](/claim/clm_0E5C9D130473.md) - 2023-01-31 to 2023-04-30 | total_assets | 1,627,969,000 United States dollar | superseded | [clm_32BDBB5B1D29](/claim/clm_32BDBB5B1D29.md) - 2023-01-31 to 2023-07-31 | quarterly_operating_income | -69,347,000 United States dollar | superseded | [clm_49934CE66B3F](/claim/clm_49934CE66B3F.md) - 2023-01-31 to 2023-07-31 | quarterly_research_and_development | 77,472,000 United States dollar | superseded | [clm_4A8E485E0201](/claim/clm_4A8E485E0201.md) - 2023-01-31 to 2023-07-31 | quarterly_revenue | 274,566,000 United States dollar | superseded | [clm_4EA5EE712DA4](/claim/clm_4EA5EE712DA4.md) - 2023-01-31 to 2023-04-30 | total_equity | 384,989,000 United States dollar | superseded | [clm_893DCBA310B0](/claim/clm_893DCBA310B0.md) - 2023-01-31 to 2023-07-31 | quarterly_net_income | -72,574,000 United States dollar | superseded | [clm_BDBEC1547F0E](/claim/clm_BDBEC1547F0E.md) - 2023-02-28 to 2023-05-31 | shares_outstanding | 96,492,357 shares | superseded | [clm_C94895867B9E](/claim/clm_C94895867B9E.md) - 2023-04-30 to 2024-04-30 | research_and_development | 313,454,000 United States dollar | superseded | [clm_32345D4D8DF0](/claim/clm_32345D4D8DF0.md) - 2023-04-30 to 2023-07-31 | cash_and_equivalents | 644,167,000 United States dollar | superseded | [clm_367DEEB51112](/claim/clm_367DEEB51112.md) - 2023-04-30 to 2024-04-30 | net_income | -236,161,000 United States dollar | superseded | [clm_9C63BD4B1A27](/claim/clm_9C63BD4B1A27.md) - 2023-04-30 to 2024-04-30 | operating_income | -219,172,000 United States dollar | superseded | [clm_A6930CF4CF12](/claim/clm_A6930CF4CF12.md) - 2023-04-30 to 2023-07-31 | total_assets | 1,743,482,000 United States dollar | superseded | [clm_ACC2D2ECFAF9](/claim/clm_ACC2D2ECFAF9.md) - 2023-04-30 to 2023-07-31 | total_equity | 398,897,000 United States dollar | superseded | [clm_B8F6A5389113](/claim/clm_B8F6A5389113.md) - 2023-04-30 to 2024-04-30 | revenue | 1,068,989,000 United States dollar | superseded | [clm_D0473312BFEA](/claim/clm_D0473312BFEA.md) - 2023-05-31 to 2023-08-21 | shares_outstanding | 97,390,886 shares | superseded | [clm_CA02052AA9B5](/claim/clm_CA02052AA9B5.md) - 2023-07-31 to 2023-10-31 | cash_and_equivalents | 630,565,000 United States dollar | superseded | [clm_1645E1723EB8](/claim/clm_1645E1723EB8.md) - 2023-07-31 to 2023-10-31 | quarterly_research_and_development | 80,690,000 United States dollar | superseded | [clm_482E9FBEEABB](/claim/clm_482E9FBEEABB.md) - 2023-07-31 to 2023-10-31 | quarterly_net_income | -48,508,000 United States dollar | superseded | [clm_7F7B687318E5](/claim/clm_7F7B687318E5.md) - 2023-07-31 to 2023-10-31 | total_assets | 1,701,410,000 United States dollar | superseded | [clm_C179F38178F7](/claim/clm_C179F38178F7.md) - 2023-07-31 to 2023-10-31 | quarterly_operating_income | -36,247,000 United States dollar | superseded | [clm_E015CF93D665](/claim/clm_E015CF93D665.md) - 2023-07-31 to 2023-10-31 | total_equity | 411,723,000 United States dollar | superseded | [clm_E6858D017F12](/claim/clm_E6858D017F12.md) - 2023-07-31 to 2023-10-31 | quarterly_revenue | 293,753,000 United States dollar | superseded | [clm_EEC963C5362B](/claim/clm_EEC963C5362B.md) - 2023-08-21 to 2023-11-28 | shares_outstanding | 98,419,072 shares | superseded | [clm_1D32AE8B9D6D](/claim/clm_1D32AE8B9D6D.md) - 2023-10-31 to 2024-01-31 | total_equity | 455,136,000 United States dollar | superseded | [clm_0E7C10C97C5E](/claim/clm_0E7C10C97C5E.md) - 2023-10-31 to 2024-01-31 | cash_and_equivalents | 589,685,000 United States dollar | superseded | [clm_17DB7452815F](/claim/clm_17DB7452815F.md) - 2023-10-31 to 2024-01-31 | quarterly_research_and_development | 80,108,000 United States dollar | superseded | [clm_5C153711D327](/claim/clm_5C153711D327.md) - 2023-10-31 to 2024-01-31 | quarterly_net_income | -24,796,000 United States dollar | superseded | [clm_771364A4E2EB](/claim/clm_771364A4E2EB.md) - 2023-10-31 to 2024-01-31 | quarterly_revenue | 310,612,000 United States dollar | superseded | [clm_E48C87B7F451](/claim/clm_E48C87B7F451.md) - 2023-10-31 to 2024-01-31 | total_assets | 1,757,846,000 United States dollar | superseded | [clm_EEF802C2E072](/claim/clm_EEF802C2E072.md) - 2023-10-31 to 2024-01-31 | quarterly_operating_income | -21,539,000 United States dollar | superseded | [clm_FEF40FC0CFB7](/claim/clm_FEF40FC0CFB7.md) - 2023-11-28 to 2024-02-26 | shares_outstanding | 99,630,496 shares | superseded | [clm_85DD20F60E6B](/claim/clm_85DD20F60E6B.md) ## 2024 - 2024-01-31 to 2024-04-30 | cash_and_equivalents | 526,893,000 United States dollar | superseded | [clm_246B8933A02C](/claim/clm_246B8933A02C.md) - 2024-01-31 to 2024-04-30 | total_equity | 707,837,000 United States dollar | superseded | [clm_358D975B509A](/claim/clm_358D975B509A.md) - 2024-01-31 to 2024-07-31 | quarterly_revenue | 327,957,000 United States dollar | superseded | [clm_3EBBB4AEFEF9](/claim/clm_3EBBB4AEFEF9.md) - 2024-01-31 to 2024-07-31 | quarterly_research_and_development | 87,202,000 United States dollar | superseded | [clm_82DE719F63EF](/claim/clm_82DE719F63EF.md) - 2024-01-31 to 2024-07-31 | quarterly_operating_income | -26,404,000 United States dollar | superseded | [clm_9630840EF5C6](/claim/clm_9630840EF5C6.md) - 2024-01-31 to 2024-04-30 | total_assets | 2,058,922,000 United States dollar | superseded | [clm_AA00F8617D12](/claim/clm_AA00F8617D12.md) - 2024-01-31 to 2024-07-31 | quarterly_net_income | 176,124,000 United States dollar | superseded | [clm_CB629082E82A](/claim/clm_CB629082E82A.md) - 2024-02-26 to 2024-05-31 | shares_outstanding | 100,807,523 shares | superseded | [clm_B0368D74C392](/claim/clm_B0368D74C392.md) - 2024-04-30 to 2025-04-30 | operating_income | -129,902,000 United States dollar | superseded | [clm_40489EACB6E4](/claim/clm_40489EACB6E4.md) - 2024-04-30 to 2025-04-30 | research_and_development | 341,951,000 United States dollar | superseded | [clm_8F614D17588B](/claim/clm_8F614D17588B.md) - 2024-04-30 to 2024-10-31 | cash_and_equivalents | 540,397,000 United States dollar | superseded | [clm_994792FC83A0](/claim/clm_994792FC83A0.md) - 2024-04-30 to 2024-07-31 | total_equity | 738,185,000 United States dollar | superseded | [clm_B934D94C798B](/claim/clm_B934D94C798B.md) - 2024-04-30 to 2024-10-31 | total_assets | 2,242,566,000 United States dollar | superseded | [clm_BCB8775610F1](/claim/clm_BCB8775610F1.md) - 2024-04-30 to 2025-04-30 | revenue | 1,267,321,000 United States dollar | superseded | [clm_BDA5949FF9EA](/claim/clm_BDA5949FF9EA.md) - 2024-04-30 to 2025-04-30 | net_income | 61,720,000 United States dollar | superseded | [clm_F8C657A3C49C](/claim/clm_F8C657A3C49C.md) - 2024-05-31 to 2024-11-18 | shares_outstanding | 101,715,185 shares | superseded | [clm_155738DA79D9](/claim/clm_155738DA79D9.md) - 2024-07-31 to 2024-10-31 | total_equity | 759,418,000 United States dollar | superseded | [clm_10362E24624A](/claim/clm_10362E24624A.md) - 2024-07-31 to 2024-10-31 | quarterly_revenue | 347,420,000 United States dollar | superseded | [clm_4703775BF0BC](/claim/clm_4703775BF0BC.md) - 2024-07-31 to 2024-10-31 | quarterly_research_and_development | 89,332,000 United States dollar | superseded | [clm_79D745AB48B9](/claim/clm_79D745AB48B9.md) - 2024-07-31 to 2024-10-31 | quarterly_net_income | -49,227,000 United States dollar | superseded | [clm_81487F2A7A7D](/claim/clm_81487F2A7A7D.md) - 2024-07-31 to 2024-10-31 | quarterly_operating_income | -33,838,000 United States dollar | superseded | [clm_828C808FFB33](/claim/clm_828C808FFB33.md) - 2024-10-31 to 2025-01-31 | total_equity | 811,518,000 United States dollar | superseded | [clm_23EACFCD0FF9](/claim/clm_23EACFCD0FF9.md) - 2024-10-31 to 2025-01-31 | quarterly_net_income | -25,450,000 United States dollar | superseded | [clm_52A34FCB083A](/claim/clm_52A34FCB083A.md) - 2024-10-31 to 2025-01-31 | cash_and_equivalents | 658,508,000 United States dollar | superseded | [clm_9910E1B07EED](/claim/clm_9910E1B07EED.md) - 2024-10-31 to 2025-01-31 | quarterly_research_and_development | 88,163,000 United States dollar | superseded | [clm_A310CA15E3D3](/claim/clm_A310CA15E3D3.md) - 2024-10-31 to 2025-01-31 | quarterly_operating_income | -4,426,000 United States dollar | superseded | [clm_A696BEC554D6](/claim/clm_A696BEC554D6.md) - 2024-10-31 to 2025-01-31 | total_assets | 2,231,500,000 United States dollar | superseded | [clm_B2C038C7CF43](/claim/clm_B2C038C7CF43.md) - 2024-10-31 to 2025-01-31 | quarterly_revenue | 365,361,000 United States dollar | superseded | [clm_BB3F1E01E3D3](/claim/clm_BB3F1E01E3D3.md) - 2024-11-18 to 2025-02-24 | shares_outstanding | 103,631,586 shares | superseded | [clm_BBF397171CAA](/claim/clm_BBF397171CAA.md) - 2024-12-14 | cfo | Eric Prengel | valid | [clm_C1E12354F904](/claim/clm_C1E12354F904.md) ## 2025 - 2025-01-31 to 2025-07-31 | quarterly_net_income | -17,056,000 United States dollar | superseded | [clm_279E23BD6B4C](/claim/clm_279E23BD6B4C.md) - 2025-01-31 to 2025-07-31 | quarterly_revenue | 382,083,000 United States dollar | superseded | [clm_48A331A03B00](/claim/clm_48A331A03B00.md) - 2025-01-31 to 2025-04-30 | cash_and_equivalents | 584,010,000 United States dollar | superseded | [clm_AA9F82920BFB](/claim/clm_AA9F82920BFB.md) - 2025-01-31 to 2025-04-30 | total_assets | 2,330,147,000 United States dollar | superseded | [clm_B22C493B81E3](/claim/clm_B22C493B81E3.md) - 2025-01-31 to 2025-07-31 | quarterly_research_and_development | 93,598,000 United States dollar | superseded | [clm_BAABA93FB78D](/claim/clm_BAABA93FB78D.md) - 2025-01-31 to 2025-07-31 | quarterly_operating_income | -4,638,000 United States dollar | superseded | [clm_D6B1D2B0AF3D](/claim/clm_D6B1D2B0AF3D.md) - 2025-01-31 to 2025-04-30 | total_equity | 859,106,000 United States dollar | superseded | [clm_F8EF2F6600F9](/claim/clm_F8EF2F6600F9.md) - 2025-02-24 to 2025-05-31 | shares_outstanding | 104,412,817 shares | superseded | [clm_BB7596CE5744](/claim/clm_BB7596CE5744.md) - 2025-02-28 | cfo | Navam Welihinda | valid | [clm_D274EA70F743](/claim/clm_D274EA70F743.md) - 2025-04-30 to 2025-07-31 | total_assets | 2,592,853,000 United States dollar | superseded | [clm_10BC19543CC8](/claim/clm_10BC19543CC8.md) - 2025-04-30 to 2025-07-31 | cash_and_equivalents | 727,543,000 United States dollar | superseded | [clm_591733243F47](/claim/clm_591733243F47.md) - 2025-04-30 to 2026-04-30 | operating_income | -54,922,000 United States dollar | superseded | [clm_660DEE6D0BA3](/claim/clm_660DEE6D0BA3.md) - 2025-04-30 to 2026-04-30 | net_income | -108,114,000 United States dollar | superseded | [clm_9E8911AAD0C6](/claim/clm_9E8911AAD0C6.md) - 2025-04-30 to 2026-04-30 | revenue | 1,483,296,000 United States dollar | superseded | [clm_CC2FE139592F](/claim/clm_CC2FE139592F.md) - 2025-04-30 to 2026-04-30 | research_and_development | 365,758,000 United States dollar | superseded | [clm_D8837D21E832](/claim/clm_D8837D21E832.md) - 2025-04-30 to 2025-07-31 | total_equity | 927,234,000 United States dollar | superseded | [clm_E8414DCA021E](/claim/clm_E8414DCA021E.md) - 2025-05-31 to 2025-08-21 | shares_outstanding | 105,534,887 shares | superseded | [clm_6D4DD911C20F](/claim/clm_6D4DD911C20F.md) - 2025-07-31 to 2025-10-31 | quarterly_net_income | -24,603,000 United States dollar | superseded | [clm_28BD6007AA83](/claim/clm_28BD6007AA83.md) - 2025-07-31 to 2025-10-31 | total_equity | 971,356,000 United States dollar | superseded | [clm_47B8DC1C7879](/claim/clm_47B8DC1C7879.md) - 2025-07-31 to 2025-10-31 | quarterly_operating_income | -9,440,000 United States dollar | superseded | [clm_60AE7EE922AD](/claim/clm_60AE7EE922AD.md) - 2025-07-31 to 2025-10-31 | total_assets | 2,524,002,000 United States dollar | superseded | [clm_6CD23DEFCCF7](/claim/clm_6CD23DEFCCF7.md) - 2025-07-31 to 2025-10-31 | quarterly_research_and_development | 109,122,000 United States dollar | superseded | [clm_7799B6B5D647](/claim/clm_7799B6B5D647.md) - 2025-07-31 to 2025-10-31 | quarterly_revenue | 415,288,000 United States dollar | superseded | [clm_BEFCBFAAB250](/claim/clm_BEFCBFAAB250.md) - 2025-07-31 to 2025-10-31 | cash_and_equivalents | 662,338,000 United States dollar | superseded | [clm_E0DD0F88E915](/claim/clm_E0DD0F88E915.md) - 2025-08-21 to 2025-11-17 | shares_outstanding | 106,270,940 shares | superseded | [clm_7870E83EA19C](/claim/clm_7870E83EA19C.md) - 2025-10-31 to 2026-01-31 | quarterly_net_income | -51,284,000 United States dollar | superseded | [clm_094E2EC19291](/claim/clm_094E2EC19291.md) - 2025-10-31 to 2026-01-31 | quarterly_revenue | 423,481,000 United States dollar | superseded | [clm_514BAD4B367A](/claim/clm_514BAD4B367A.md) - 2025-10-31 to 2026-01-31 | total_assets | 2,476,570,000 United States dollar | superseded | [clm_6E99DA61077B](/claim/clm_6E99DA61077B.md) - 2025-10-31 to 2026-01-31 | total_equity | 891,112,000 United States dollar | superseded | [clm_93E03F2A63C9](/claim/clm_93E03F2A63C9.md) - 2025-10-31 to 2026-01-31 | cash_and_equivalents | 800,586,000 United States dollar | superseded | [clm_A6F3762C514A](/claim/clm_A6F3762C514A.md) - 2025-10-31 to 2026-01-31 | quarterly_research_and_development | 108,152,000 United States dollar | superseded | [clm_B8B08AD86561](/claim/clm_B8B08AD86561.md) - 2025-10-31 to 2026-01-31 | quarterly_operating_income | -8,236,000 United States dollar | superseded | [clm_BBE73E0264FC](/claim/clm_BBE73E0264FC.md) - 2025-11-17 to 2026-02-23 | shares_outstanding | 105,372,800 shares | superseded | [clm_48475D88D529](/claim/clm_48475D88D529.md) ## 2026 - 2026-01-31 to 2026-07-31 | quarterly_operating_income | 611,000 United States dollar | superseded | [clm_5A5D3EE4B4BE](/claim/clm_5A5D3EE4B4BE.md) - 2026-01-31 to 2026-04-30 | total_assets | 2,438,415,000 United States dollar | superseded | [clm_613EFA7F0E92](/claim/clm_613EFA7F0E92.md) - 2026-01-31 to 2026-04-30 | total_equity | 790,991,000 United States dollar | superseded | [clm_7C71E7A19108](/claim/clm_7C71E7A19108.md) - 2026-01-31 to 2026-07-31 | quarterly_research_and_development | 114,390,000 United States dollar | superseded | [clm_9CA4AC78F500](/claim/clm_9CA4AC78F500.md) - 2026-01-31 to 2026-07-31 | quarterly_net_income | 7,753,000 United States dollar | superseded | [clm_C4BD64CFB454](/claim/clm_C4BD64CFB454.md) - 2026-01-31 to 2026-07-31 | quarterly_revenue | 449,881,000 United States dollar | superseded | [clm_E229A83909F1](/claim/clm_E229A83909F1.md) - 2026-01-31 to 2026-04-30 | cash_and_equivalents | 737,238,000 United States dollar | superseded | [clm_ED9053E38897](/claim/clm_ED9053E38897.md) - 2026-02-23 to 2026-05-29 | shares_outstanding | 103,501,008 shares | superseded | [clm_F5E986B6535E](/claim/clm_F5E986B6535E.md) - 2026-04-30 | research_and_development | 451,925,000 United States dollar | valid | [clm_27644C70A304](/claim/clm_27644C70A304.md) - 2026-04-30 | operating_income | -33,476,000 United States dollar | valid | [clm_2CFF0336433F](/claim/clm_2CFF0336433F.md) - 2026-04-30 to 2026-07-31 | cash_and_equivalents | 768,725,000 United States dollar | superseded | [clm_2E9945003326](/claim/clm_2E9945003326.md) - 2026-04-30 | revenue | 1,739,331,000 United States dollar | valid | [clm_405FDD647C26](/claim/clm_405FDD647C26.md) - 2026-04-30 | net_income | 367,766,000 United States dollar | valid | [clm_92B76EF93182](/claim/clm_92B76EF93182.md) - 2026-04-30 to 2026-07-31 | total_assets | 3,152,676,000 United States dollar | superseded | [clm_E9F7351DEF1B](/claim/clm_E9F7351DEF1B.md) - 2026-04-30 to 2026-07-31 | total_equity | 1,276,500,000 United States dollar | superseded | [clm_F4A1096F6A5D](/claim/clm_F4A1096F6A5D.md) - 2026-05-29 to 2026-08-21 | shares_outstanding | 103,951,633 shares | superseded | [clm_41A6292E399A](/claim/clm_41A6292E399A.md) - 2026-06-23 | restructuring | Workforce reduction of about 7% to align investments with strategic priorities | valid | [clm_6908353E4EA1](/claim/clm_6908353E4EA1.md) - 2026-07-31 | quarterly_net_income | -16,729,000 United States dollar | valid | [clm_05B851E70CDD](/claim/clm_05B851E70CDD.md) - 2026-07-31 | total_assets | 3,001,888,000 United States dollar | valid | [clm_0901BCEDB87D](/claim/clm_0901BCEDB87D.md) - 2026-07-31 | quarterly_research_and_development | 112,493,000 United States dollar | valid | [clm_3ECC75FA6F07](/claim/clm_3ECC75FA6F07.md) - 2026-07-31 | cash_and_equivalents | 879,869,000 United States dollar | valid | [clm_76B121D6F3B5](/claim/clm_76B121D6F3B5.md) - 2026-07-31 | quarterly_revenue | 478,113,000 United States dollar | valid | [clm_79F74C0187E7](/claim/clm_79F74C0187E7.md) - 2026-07-31 | quarterly_operating_income | -23,574,000 United States dollar | valid | [clm_974223C24BE6](/claim/clm_974223C24BE6.md) - 2026-07-31 | total_equity | 1,296,843,000 United States dollar | valid | [clm_FFE0D648FE64](/claim/clm_FFE0D648FE64.md) - 2026-08-21 | shares_outstanding | 104,991,280 shares | valid | [clm_929A0FA71EED](/claim/clm_929A0FA71EED.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.